FDARA Timing Murky, But Potential Floor Amendments Taking Shape

With the Senate's last-ditch effort to pass an Affordable Care Act repeal bill defeated, sources tell Inside Health Policy that the chamber has yet to settle on a date to consider must-pass FDA user fee reauthorization legislation, but point to the first week of September as a likely timeline. A package of amendments to be debated on the floor is starting to take shape, with topics said to include a variety of drug pricing ideas, a federal Right to Try...